Flyer: Monkeypox oligos – Primers & Probes
Posted: 17 November 2022 | Merck | No comments yet
Monkeypox oligos – Primers & Probes for Research & Commercial use.
The outbreak of Monkeypox has increased the demand for primers and probes for qPCR-based detection.
We are committed to providing researchers and assay developers with the products, reagents and technical expertise to address the Monkeypox outbreak.
Rely on our 35+ years of experience and global supply chain to provide you with expertly manufactured and reliably delivered oligos.
Related content from this organisation
- Moderna-Merck & Co cancer vaccine with Keytruda shows late-stage promise
- Raman-based PAT tool could advance continuous vaccine manufacturing
- Merck acquires JSR Life Sciences chromatography business
- MSD acquisition to accelerate first-in-class COPD drug
- Next drug patent cliff to challenge Big Pharma strategy
